EC

EcoR1 Capital Portfolio holdings

AUM $1.69B
This Quarter Return
+4.24%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$3.13B
AUM Growth
+$3.13B
Cap. Flow
+$493M
Cap. Flow %
15.74%
Top 10 Hldgs %
65.45%
Holding
90
New
19
Increased
10
Reduced
3
Closed
13

Top Buys

1
APLS icon
Apellis Pharmaceuticals
APLS
$191M
2
CRSP icon
CRISPR Therapeutics
CRSP
$81.7M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
$71.4M
4
TSVT
2seventy bio
TSVT
$49.1M
5
AVIR icon
Atea Pharmaceuticals
AVIR
$48.1M

Top Sells

1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$82.1M
2
STTK icon
Shattuck Labs
STTK
$75.6M
3
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$25.2M
4
NRIX icon
Nurix Therapeutics
NRIX
$23.7M
5
BLUE
bluebird bio
BLUE
$15.3M

Sector Composition

1 Healthcare 99.03%
2 Financials 0.62%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EWTX icon
26
Edgewise Therapeutics
EWTX
$1.54B
$19.5M 0.62%
1,279,175
– –
OVID icon
27
Ovid Therapeutics
OVID
$94.6M
$19.5M 0.62%
6,082,200
– –
AKUS
28
DELISTED
Akouos, Inc. Common Stock
AKUS
$16.8M 0.54%
1,975,984
– –
CRNX icon
29
Crinetics Pharmaceuticals
CRNX
$3.26B
$16.8M 0.53%
+590,169
New +$16.8M
ALNY icon
30
Alnylam Pharmaceuticals
ALNY
$58.6B
$16.6M 0.53%
+98,146
New +$16.6M
SLDB icon
31
Solid Biosciences
SLDB
$448M
$16.1M 0.51%
9,202,702
– –
HALO icon
32
Halozyme
HALO
$8.75B
$15.8M 0.5%
+392,000
New +$15.8M
LEGN icon
33
Legend Biotech
LEGN
$6.64B
$14.3M 0.46%
+307,594
New +$14.3M
TNGX icon
34
Tango Therapeutics
TNGX
$745M
$14.2M 0.45%
1,300,000
– –
ERAS icon
35
Erasca
ERAS
$406M
$10.9M 0.35%
700,000
– –
ARVN icon
36
Arvinas
ARVN
$580M
$10.7M 0.34%
+130,300
New +$10.7M
CNTA
37
Centessa Pharmaceuticals
CNTA
$2.13B
$9.93M 0.32%
882,176
+127,631
+17% +$1.44M
IMVT icon
38
Immunovant
IMVT
$2.91B
$9.72M 0.31%
1,140,819
– –
VYGR icon
39
Voyager Therapeutics
VYGR
$204M
$9.64M 0.31%
3,557,507
+3,111,515
+698% +$8.43M
NRIX icon
40
Nurix Therapeutics
NRIX
$723M
$8.96M 0.29%
309,540
-817,100
-73% -$23.7M
LENZ
41
LENZ Therapeutics
LENZ
$1.12B
$8.56M 0.27%
+688,900
New +$8.56M
NUVB.WS icon
42
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$63.9M
$8.19M 0.26%
963,333
– –
SPRY icon
43
ARS Pharmaceuticals
SPRY
$1.08B
$7.06M 0.23%
1,060,010
-124,700
-11% -$831K
CCCC icon
44
C4 Therapeutics
CCCC
$182M
$6.44M 0.21%
200,000
– –
FLAC
45
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
$5.73M 0.18%
587,615
– –
AMTI
46
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$5.59M 0.18%
+400,000
New +$5.59M
KRON
47
DELISTED
Kronos Bio
KRON
$5.26M 0.17%
387,357
– –
JYAC
48
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$4.89M 0.16%
500,000
– –
NGNE icon
49
Neurogene
NGNE
$284M
$4.15M 0.13%
860,619
– –
OBIO icon
50
Orchestra BioMed
OBIO
$147M
$4.03M 0.13%
400,000
– –
1
2
3 4